AZTREONAM IN CAPD PERITONITIS

The Lancet

Volumn 330, Issue 8552, 1987, Pages 213-214

  Dratwa, M ^a   Glupczynski, Y ^a   Lameire, N ^b   Matthys, D ^b   Verschraegen, G ^b   Van Eeckhoute, M ^b   Boelaert, J ^c   Schurgers, M ^c   Van Landuyt, H ^c   Verbeelen, D ^d   Lauwers, S ^d  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c General Hospital St John Bruges   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CLOXACILLIN; COTRIMOXAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ADVERSE DRUG REACTION; CATHETER INFECTION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIALYSIS; DRUG COMPARISON; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOXICITY; EDITORIAL; GRAM NEGATIVE BACTERIUM; HUMAN; INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; LARGE INTESTINE; LETTER; ORAL DRUG ADMINISTRATION; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; THERAPY;

AZTREONAM; BACTERIAL INFECTIONS; CLINICAL TRIALS; GRAM-NEGATIVE BACTERIA; HUMANS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS;

EID: 0023184143     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(87)90789-6     Document Type: Letter

References (3)

1. Safety of aztreonam and SQ26,992 in elderly patients with renal insufficiency
2. Ambulatory peritonitis
3. Pseudomonas peritonitis and continuous ambulatory pentoneal dialysis